Charles A. Kunos Department of Radiation Oncology Summa Cancer Institute Biography Publications Institution JoVE Articles Charles A. Kunos has not added a biography. If you are Charles A. Kunos and would like to personalize this page please email our Author Liaison for assistance. Publications Determination of Triapine, a Ribonucleotide Reductase Inhibitor, in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry Biomedical Chromatography : BMC. Feb, 2015 | Pubmed ID: 25677991 Two-step Procedure for Evaluating Experimentally Induced DNA Damage: Texas Red and Comet Assays Methods in Molecular Biology (Clifton, N.J.). 2015 | Pubmed ID: 25348306 Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-based Brachytherapy in Locally Advanced Cervical Cancer International Journal of Radiation Oncology, Biology, Physics. Oct, 2014 | Pubmed ID: 25304792 Hydration During Breast Radiotherapy May Lower Skin Toxicity The Breast Journal. Nov-Dec, 2014 | Pubmed ID: 25252223 Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer Frontiers in Oncology. 2014 | Pubmed ID: 25105092 Novel Biological Radiochemotherapy Approaches in Locally Advanced-stage Cervical Cancer Management Discovery Medicine. Apr, 2014 | Pubmed ID: 24759622 Acute Gastrointestinal Toxicity After Robotic Stereotactic Ablative Radiotherapy for Treatment of Metastatic Gynecological Malignancies Future Oncology (London, England). Feb, 2014 | Pubmed ID: 24490610 Lymphovascular Space Invasion (LVSI) is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women with Intermediate- to High-risk Early-stage Endometrioid Endometrial Cancer International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Oct, 2013 | Pubmed ID: 24257558 Cabazitaxel-induced Stabilization of Microtubules Enhances Radiosensitivity in Ovarian Cancer Cells Frontiers in Oncology. 2013 | Pubmed ID: 24066277 Role of Stereotactic Radiosurgery in Gynecologic Cancer Current Opinion in Oncology. Sep, 2013 | Pubmed ID: 23942297 Radiation Quality, Like Art, Consists in Drawing the Line Somewhere Frontiers in Oncology. 2013 | Pubmed ID: 23882449 Radiochemotherapy Plus 3-aminopyridine-2-carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) in Advanced-stage Cervical and Vaginal Cancers Gynecologic Oncology. Jul, 2013 | Pubmed ID: 23603372 Emerging Role of Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer Expert Review of Anticancer Therapy. Apr, 2013 | Pubmed ID: 23560842 Ribonucleotide Reductase Expression in Cervical Cancer: a Radiation Therapy Oncology Group Translational Science Analysis International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. May, 2013 | Pubmed ID: 23552804 Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies Frontiers in Oncology. 2012 | Pubmed ID: 23227452 DNTP Supply Gene Expression Patterns After P53 Loss Cancers. Nov, 2012 | Pubmed ID: 23205301 Elevated Ribonucleotide Reductase Levels Associate with Suppressed Radiochemotherapy Response in Human Cervical Cancers International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Nov, 2012 | Pubmed ID: 23051959 Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer Oncology & Hematology Review. 2012 | Pubmed ID: 22943045 Hematological Toxicity After Robotic Stereotactic Body Radiosurgery for Treatment of Metastatic Gynecologic Malignancies International Journal of Radiation Oncology, Biology, Physics. Sep, 2012 | Pubmed ID: 22543208 3-氨基吡啶-2-甲醛缩氨基硫脲引起高铁血红蛋白症的管理。 Future Oncology (London, England). Feb, 2012 | Pubmed ID: 22335579 对非单调的数据模型集成分析。 Nucleosides, Nucleotides & Nucleic Acids. 2012 | Pubmed ID: 22303993 (18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies Journal of Nuclear Medicine & Radiation Therapy. Dec, 2011 | Pubmed ID: 25506042 Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies Gynecology & Obstetrics (Sunnyvale, Calif.). Dec, 2011 | Pubmed ID: 25392744 在妇科肿瘤中的机器人手术。 Obstetrics and Gynecology International. 2011 | Pubmed ID: 22190946 化疗加放疗中晚期子宫内膜癌。 International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Dec, 2011 | Pubmed ID: 21897269 Deoxynucleoside 抢救期间核苷酸还原酶封锁在人类宫颈癌促进 DNA 修复。 Radiation Research. Oct, 2011 | Pubmed ID: 21756082 通过抑制核苷酸还原酶细胞人类宫颈癌的放射增敏作用: 增强低剂量率辐射反应。 International Journal of Radiation Oncology, Biology, Physics. Jul, 2011 | Pubmed ID: 21470790 低剂量多西他赛治疗复发性卵巢癌化疗增敏腹部辐射: 我研究妇科肿瘤学组的一个阶段。 Gynecologic Oncology. Feb, 2011 | Pubmed ID: 21075438 加入后高剂量率腔内的照射治疗子宫内膜癌的阴道扩张。 International Journal of Radiation Oncology, Biology, Physics. Jul, 2011 | Pubmed ID: 20619551 核苷酸还原酶抑制作用增强了人类宫颈癌 Chemoradiosensitivity。 Radiation Research. Nov, 2010 | Pubmed ID: 20954859 第一阶段审判的骨盆放射、 每周顺铂和 3-氨基吡啶-2-甲醛缩硫脲 (NSC #663249-AP 3) 治疗局部晚期宫颈癌。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2010 | Pubmed ID: 20145183 通过抑制癌症与病毒式或 Mutationally 沉默的 P53 蛋白核苷酸还原酶调节耐辐射性。 Radiation Research. Dec, 2009 | Pubmed ID: 19929413 除毛切除的腹膜后肉瘤放射治疗导致长期生存: 单一的机构研究的结果。 Journal of Oncology. 2008 | Pubmed ID: 19277103 与常规的辐射提供腹侧辐射螺旋放疗的比较。 Technology in Cancer Research & Treatment. Jun, 2008 | Pubmed ID: 18473494 对使用米克喷枪的前列腺癌免费植入放射性种子的迁移。 Brachytherapy. 2004 | Pubmed ID: 15374538 动态肺肿瘤跟踪烧蚀立体定向放射身体治疗 Charles A. Kunos1, Jeffrey M. Fabien1, John P. Shanahan1, Christine Collen2, Thierry Gevaert2, Kenneth Poels2, Robbe Van den Begin2, Benedikt Engels2, Mark De Ridder2 1Department of Radiation Oncology, Summa Cancer Institute, 2Department of Radiation Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Médecine
动态肺肿瘤跟踪烧蚀立体定向放射身体治疗 Charles A. Kunos1, Jeffrey M. Fabien1, John P. Shanahan1, Christine Collen2, Thierry Gevaert2, Kenneth Poels2, Robbe Van den Begin2, Benedikt Engels2, Mark De Ridder2 1Department of Radiation Oncology, Summa Cancer Institute, 2Department of Radiation Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Médecine